Navigation Links
CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
Date:10/6/2009

SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a new clinical and medical products corporation, has received No. 1 rankings by independent market research firms for two of the corporation's key brands. CareFusion's Pyxis® technologies were again named number one in user satisfaction ratings in MD Buyline's 2009 third quarter report (July through September) for the third consecutive quarter; and CareFusion's MedMined(TM) Services received the annual top ranking for infection surveillance technology providers by KLAS, published in August 2009.

"These rankings reflect our commitment to deliver superior customer service and innovative medical technologies that are clinically proven to improve patient care," said Dave Schlotterbeck, chairman and chief executive officer of CareFusion. "While CareFusion is a new company, we have a long history of helping hospitals and medical facilities improve health care delivery in terms of effectiveness, cost efficiencies and, most importantly, patient safety."

MD Buyline collects technology evaluations from health care providers and tallies the scores based on a 12-month rolling average score. KLAS' ratings are based on the overall performance calculated from individual scores for each of 40 criteria, consisting of 28 performance indicators and 12 business indicators based on a 100-point scale.

CareFusion's Pyxis® technologies for managing medications and supplies have been shown to reduce supply costs by 50 percent(1) and help to protect 1.5 million patients annually from medication errors(2). Additionally, CareFusion estimates that its MedMined(TM) Services has the potential to help hospitals save 6,800 lives and $1 billion in health care costs annually by helping to identify at-risk patients and ways to reduce health care-acquired infections (HAIs)(3).

Pyxis® Technologies will be highlighted at the upcoming Managing Today's OR Suite (MTORS) Conference and Exhibition in Las Vegas, Nev., from October 7-8, 2009.

About the MD Buyline and KLAS Rankings

MD Buyline provides the most comprehensive database of information on health care products. MD Buyline members use the data to make informed decisions, which enables cost savings and operational efficiencies.

KLAS is a research firm specializing in monitoring and reporting the performance of health care vendors. KLAS' mission is to improve delivery of care, by independently measuring vendor performance for the benefit of health care providers, consultants, investors, and vendors. The 2009 KLAS report, Infection Control: Improving Patient Care and Reimbursements, highlights the recent growth and leading vendors in the market for infection control software, which analyzes data from various hospital departments to identify potential infections.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

    (1) St. John's Medical Center. CareFusion, 2007.
    (2) Preventing Medication Errors: Quality Chasm Series. Institute of
        Medicine, July 2006.
    (3) Projection based on aggregate internal analysis of 174 MedMined
        services clients' performance between August 2006 and October 2008.

SOURCE CareFusion Corporation


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award
2. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
5. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
6. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
7. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
8. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
9. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
10. Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
11. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Md. , Feb. 23, 2017 ... marketing of the PhenoTest BC Kit, performed on ... to identify organisms that cause bloodstream infections and ... likely to respond to (antibiotic sensitivity). The test ... to provide this important information, which can guide ...
(Date:2/24/2017)... 24 février 2017 ITL Limited, ( ASX : ITD ), ... ravie d,annoncer les excellents résultats semestriels clos le 31 ... Une présentation complète « Résultats et mise à jour sur ... . Faits marquants ... 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a ... an astounding statement when he says that the entire Bible was written for the ... times so plainly that anyone should be able to see the time period. He ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, ... a letter to withdraw previous guidance issued by the Obama Administration requiring ... issued in May 2016 by the Obama Administration came in response to a ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
Breaking Medicine News(10 mins):